![]() |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
England and Wales Court of Appeal (Civil Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales Court of Appeal (Civil Division) Decisions >> Mayne Pharma PTY Ltd & Anor v Pharmacia Italia SPA [2005] EWCA Civ 294 (10 March 2005) URL: http://www.bailii.org/ew/cases/EWCA/Civ/2005/294.html Cite as: [2005] EWCA Civ 294 |
[New search] [Printable RTF version] [Help]
IN THE COURT OF APPEAL (CIVIL DIVISION)
ON APPEAL FROM THE HIGH COURT
CHANCERY DIVISION (PATENTS COURT)
(ROGER WYAND QC (SITTING AS A DEPUTY JUDGE OF THE CHANCERY DIVISION))
Strand London, WC2 |
||
B e f o r e :
(Dame Elizabeth Butler-Sloss)
LORD JUSTICE JACOB
LORD JUSTICE HOOPER
____________________
(1) MAYNE PHARMA PTY LIMITED | ||
(2) MAYNE PHARMA PLC | Claimants/Respondents | |
-v- | ||
PHARMACIA ITALIA SPA | Defendant/Appellant |
____________________
Smith Bernal Wordwave Limited
190 Fleet Street, London EC4A 2AG
Tel No: 020 7404 1400 Fax No: 020 7831 8838
Official Shorthand Writers to the Court)
MR C BIRSS (instructed by Taylor Wessing) appeared on behalf of the Respondents
____________________
Crown Copyright ©
Judgment on Costs Thursday, 10th March 2005
"In this case the products cannot, while they remain outside the jurisdiction, infringe the Australian patents of the applicants. Nor is there any evidence that, unless ordered to do so by the Court, the respondents intend to re-import them. All that can be said in support of such an order is that while in Australia the products infringed the patents and that the respondents should not be allowed to "gain a benefit" by "sneaking" them out of the jurisdiction. But an order for delivery up is not for punishment of the infringer or compensation to the patentee. It is to protect the patentee's rights. As I see it, the presence of the products in Papua New Guinea does not place the rights of the applicant at risk and in need of protection. See further Blanco White, Patents for Inventions 1974 4th ed at para 12-128; Terrell on the Law of Patents 13th ed, para 14.178-14.180."
"Although initially it was suggested by Pharmacia that "reconstituted" was a term of art that was dropped and now there is no suggestion that any of the terms I must construe in the claim have a special technical meaning other than their ordinary meaning."
It was on the basis of the "ordinary meaning" that he came to his decision and it was on that basis that we came to our decision.
"We write with a view to narrowing the issues prior to the trial of the UK proceedings.
Please state whether it is your case that the term "not reconstituted from a lyophilisate" as it appears in the claims of the 311 patent (or any part of that phrase):
(a) is a term of art; or
(b) is a term which should be construed solely in light of the disclosure in the rest of the specification."
"We refer to your fax of 5 October 2004 asking whether the phrase "not reconstituted from a lyophilisate" is a term of art, or ought to be construed solely by reference to the Patent. The question is asked with a view to "narrowing the issues". The only issue in the proceedings is the proper interpretation of this phrase as it is used in the claims of the Patent. Our client's position in relation to this issue is clearly set out in Professor Stella's reports."
"We refer to your second letter of today in which you refuse to state whether it is your position that the phrase "not reconstituted from a lyophilisate" is a term of art.
We do not believe your stance is in accordance with the spirit of the CPR.
We ask you to reconsider your response."
There was no such reconsideration.
ORDER: counsel to submit agreed minute of order.